Recurrent mutations in H3F3A at K27 and G34 are frequent in pediatric glioblastoma, but it is unclear how these mutations promote tumorigenesis. In this issue of Cancer Discovery, Bjerke and colleagues identify mutations at G34 in H3F3A that result in elevated expression of MYCN as a potential mechanism in gliomagenesis. © 2013 American Association for Cancer Research.
CITATION STYLE
Huang, M., & Weiss, W. A. (2013). G34, another connection between MYCN and a pediatric tumor. Cancer Discovery, 3(5), 484–486. https://doi.org/10.1158/2159-8290.CD-13-0126
Mendeley helps you to discover research relevant for your work.